Literature DB >> 11979381

Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas.

Jesus Lomas1, M Josefa Bello, M Eva Alonso, Pilar Gonzalez-Gomez, Dolores Arjona, M Elena Kusak, Jose M de Campos, Jose L Sarasa, Juan A Rey.   

Abstract

Multiple meningiomas are rare, and only 13 cases have been subjected to molecular genetic analysis to detect mutations of the tumor-suppressor gene neurofibromatosis type 2 (NF2) located on chromosome 22. Most of these cases display NF2 gene mutations parallel to loss of the chromosome 22 homolog, indicating that inactivation of this gene may represent an early event in the development of multiple meningiomas. We report a case of a 61-year-old woman who developed multiple (dorsal and intracranial) meningiomas. Cytogenetic and molecular genetic studies demonstrated the loss of a copy of chromosome 22 in the 5 meningiomas studied and the absence of NF2 gene mutations in 4 of those available for this molecular analysis. These findings, together with similar data from 2 previously reported cases, suggest the participation of a tumor-suppressor gene other than NF2 on chromosome 22 in the pathogenesis of a subgroup of multiple meningiomas. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 11979381     DOI: 10.1053/hupa.2002.32229

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Multiple meningiomas: differential involvement of the NF2 gene in children and adults.

Authors:  D G R Evans; C Watson; A King; A J Wallace; M E Baser
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

2.  Meningiomatosis restricted to the left cerebral hemisphere with acute clinical deterioration: Case presentation and discussion of treatment options.

Authors:  Victoria Ohla; Christian Scheiwe
Journal:  Surg Neurol Int       Date:  2015-04-20

3.  Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas.

Authors:  MariaDolores Tabernero; María Jara-Acevedo; Ana B Nieto; Arancha Rodríguez Caballero; Alvaro Otero; Pablo Sousa; Jesús Gonçalves; Patricia H Domingues; Alberto Orfao
Journal:  BMC Med Genet       Date:  2013-10-30       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.